Key result
Vasodilators and pulmonary banding enable successful repair of a large VSD in Eisenmenger syndrome.
Why the study?
Although long-standing vasodilators reduce pulmonary vascular resistance in Eisenmenger syndrome, the optimal strategy to achieve stable congenital heart disease repair remains unknown.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
A sequential 'drug-and-banding' approach may reverse inoperability and allow for successful surgical repair in patients with Eisenmenger syndrome.
Eisenmenger syndrome (ES) has been considered a cause of inoperability in patients with congenital heart disease (CHD). Even if long-standing vasodilators are efficient to reduce pulmonary vascular resistance (PVR), the best approach to grant stable repair of these patients is still unknown. We describe the case of a 28-year-old man with a diagnosis of untreated large ventricular septal defect and established ES. After few years of vasodilator therapy, the patient underwent pulmonary banding with significant reduction of his PVR. His CHD was then repaired, with clinical and functional improvement at 2-year follow-up.
No takes yet. Share an insight, caveat, or question.
Pradegan et al. (2020) conducted a case report in Eisenmenger syndrome and large ventricular septal defect (n=1). Vasodilator therapy and pulmonary banding was evaluated on Clinical and functional improvement. A drug-and-banding approach using vasodilators and pulmonary banding enabled successful repair of a large ventricular septal defect in a patient with Eisenmenger syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: